Omeros (OMER) to Release Quarterly Earnings on Wednesday

Omeros (NASDAQ:OMER) is scheduled to be announcing its earnings results after the market closes on Wednesday, November 13th.

Omeros Stock Down 2.7 %

Shares of NASDAQ OMER opened at $4.29 on Tuesday. The stock has a market cap of $248.59 million, a P/E ratio of -1.83 and a beta of 1.47. The firm’s 50-day simple moving average is $4.01 and its 200 day simple moving average is $4.04. Omeros has a fifty-two week low of $1.17 and a fifty-two week high of $5.68.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Omeros from a “sell” rating to a “hold” rating in a research report on Friday, August 16th.

About Omeros

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases, including complement-mediated diseases, cancers, and addictive and compulsive disorders. The company’s products under development include Narsoplimab (OMS721/MASP-2) that has completed pivotal trial for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); that is in Phase III clinical trial for the treatment of immunoglobulin A nephropathy (IgAN); and Phase II clinical trial to treat COVID-19.